THE EFFECT OF CHAMOMILE ON PSYCHOLOGICAL WELL-BEING, DEPRESSION, ANXIETY LEVEL OF INDIVIDUALS WITH ANXIETY DISORDERS: A META-ANALYSIS STUDY

Öz

Aim: This study was conducted to examine the effect of chamomile on psychological well-being, depression and anxiety levels of individuals with anxiety disorders. Method: March May 2022, the data in this meta-analysis type study were obtained by scanning PubMed, Web of Science, EBSCOhost and Google Scholar, COHE thesis databases without going to the year limitation. After the examinations were made, 7 studies were included in the research. The total number of samples in the research is 784. Results: As a result of the research, daisy had anxiety,( (SMD: -1.313, 95% CI: 0.294- 0.087; Z= -4.462, p = 0.010, I2= 94.653%), depression (SMD: 5.762, 95% CI: 6.926- 10.921; Z= 2.190, p = 0.029, I2=98.753%) and it was determined that there is an effective variable on psychological well-being (SMD: 3.747, 95% CI: 1.621- 0.2,628; Z= 2.311, p = 0.021, I2=99.448%). Conclusions and Suggestions: In the study, it was found that chamomile use had an effect on depression, anxiety and psychological well-being in individuals with anxiety disorders. These results suggest that chamomile may produce a clinically significant antidepressant effect in individuals with anxiety disorders and may provide psychological well-being in individuals.

Anahtar Kelimeler

• Anxiety Disorders
• ; Chamomile
• Anxiety
• Depression
• Psychological Well-Being

Papatyanın Anksiyete Bozukluğu Olan Bireylerin Psikolojik İyi Oluşluluk, Depresyon, Anksiyete Düzeyi Üzerine Etkisi: Bir Meta Analiz Çalışması

Öz

Amaç: Bu çalışma, papatyanın anksiyete bozukluğu olan bireylerin psikolojik iyi oluşluk, depresyon ve anksiyete düzeyi üzerindeki etkisini incelemek amacı ile yapılmıştır. Yöntem: Meta analiz türündeki bu çalışmadaki veriler Mart-Mayıs 2022’de PubMed, Web of Scıence, EBSCOhost ve Google Akademik, YÖK tez veri tabanlarında yıl sınırlamasına gidilmeden tarama yapılarak elde edilmiştir. Araştırmaya incelemeler yapıldıktan sonra 7 araştırma dâhil edilmiştir. Araştırmalarda toplam örneklem sayısı 784’tür. Bulgular: Araştırma sonucunda papatyanın anksiyete,( (SMD: -1,313, %95 CI: 0,294- 0.087; Z= -4,462, p = 0.010, I2= %94,653), depresyon (SMD: 5,762, %95 CI: 6,926- 10,921; Z= 2,190, p = 0.029, I2= %98,753) ve psikolojik iyi oluşluk üzerinde etkili bir değişken olduğu (SMD: 3,747, %95 CI: 1,621- 0.2,628; Z= 2,311, p = 0.021, I2= %99,448) belirlenmiştir. Sonuç ve Öneriler: Çalışmada anksiyete bozukluğu olan bireylerde papatya kullanımının depresyon, anksiyete ve psikolojik iyi oluşluk üzerinde etkili olduğu bulunmuştur. Bu sonuçlar papatyanın anksiyete bozukluğu olan bireylerde klinik olarak anlamlı bir antidepresan etki üretebileceğini ve bireylerde psikolojik iyi oluşluk sağlayabileceğini düşündürmektedir.

Anahtar Kelimeler

• papatya
• anksiyete bozuklukları
• depresyon
• Psikolojik İyi Oluşluk
• Anksiyete

Kaynakça

1. Yıldız imi (*) ile işaretlenmiş kaynaklar, meta-analize dâhil edilen çalışmaları göstermektedir.
2. *Amsterdam, J. D., Li, Y., Soeller, I., Rockwell, K., Mao, J. J., & Shults, J. (2009). A randomized, double‐blind, placebo‐controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder.Journal of Clinical Psychopharmacology, 29(4), 378–382. https://doi.org/10.1097/JCP.0b013e3181ac935c.
3. *Amsterdam, J. D., Shults, J., Soeller, I., Mao, J. J., Rockwell, K., & Newberg, A. B. (2012). Chamomile (Matricaria recutita) may have antidepressant activity in anxious depressed humans-an exploratory study. Alternative Therapies In Health And Medicine, 18(5), 44.
4. *Amsterdam, J. D., Li, Q. S., Xie, S. X., & Mao, J. J. (2020). Putative Antidepressant Effect of Chamomile (Matricaria chamomilla L.) Oral Extract in Subjects with Comorbid Generalized Anxiety Disorder and Depression. Journal of Alternative and Complementary Medicine, 26(9), 815. https://doi.org/10.1089/ACM.2019.0252
5. Bandelow, B., & Michaelis, S. (2022). Epidemiology of anxiety disorders in the 21st century. Dialogues in Clinical Neuroscience, 17(3), 327–335. https://doi.org/10.31887/DCNS.2015.17.3/BBANDELOW.
6. Chang, S. M., & Chen, C. H. (2016). Effects of an intervention with drinking chamomile tea on sleep quality and depression in sleep disturbed postnatal women: a randomized controlled trial. Journal of advanced nursing, 72(2), 306-315.
7. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). New Jersey: Lawrence Erlbaum Associates, Inc. Retrieved from http://books.google.com.tr/
8. Ebrahimi, H., Mardani, A., Basirinezhad, M. H., Hamidzadeh, A., & Eskandari, F. (2022). The effects of Lavender and Chamomile essential oil inhalation aromatherapy on depression, anxiety and stress in older community-dwelling people: A randomized controlled trial. EXPLORE, 18(3), 272–278. https://doi.org/10.1016/J.EXPLORE.2020.12.012.

9. Egger, M., Smith, G. D., Schneider, M., Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. British Medical Journal, 315(7109), 629.
10. Ghamchini, V. M., Salami, M., Mohammadi, G. R., Moradi, Z., Kavosi, A., Movahedi, A., ... & Aryaeefar, M. R. (2019). The effect of chamomile tea on anxiety and depression in cancer patients treated with chemotherapy. Journal of Young Pharmacists, 11(3), 309.
11. Grissom, R. J., & Kim, J. J. (2005). Effect sizes for research: A broad practical approach. Lawrence Erlbaum Associates Publishers.
12. Hatipoğlu, H. (2021). Sistematik derleme ve meta analiz. Eskişehir Türk Dünyası Uygulama ve Araştırma Merkezi Bilişim Dergisi, 2(1), 7-10.
13. Hieu, T. H., Dibas, M., Surya Dila, K. A., Sherif, N. A., Hashmi, M. U., Mahmoud, M., Trang, N. T. T., Abdullah, L., Nghia, T. L. B., Mai Nhu, Y., Hirayama, K., & Huy, N. T. (2019). Therapeutic efficacy and safety of chamomile for state anxiety, generalized anxiety disorder, insomnia, and sleep quality: A systematic review and meta-analysis of randomized trials and quasi-randomized trials. Phytotherapy Research, 33(6), 1604–1615. https://doi.org/10.1002/PTR.6349.
14. Jabri, M. A., Rtibi, K., & Sebai, H. (2022). Chamomile decoction mitigates high fat diet-induced anxiety-like behavior, neuroinflammation and cerebral ROS overload. Nutritional Neuroscience, 25(7), 1350-1361.
15. *Keefe, J. R., Mao, J. J., Soeller, I., Li, Q. S., & Amsterdam, J. D. (2016). Short‐ term open‐label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder. Phytomedicine, 23(14), 1699–1705. https://doi.org/10.1016/j.phymed.2016.10.013.
16. *Keefe, J. R., Amsterdam, J., Li, Q. S., Soeller, I., DeRubeis, R., & Mao, J. J. (2017). Specific expectancies are associated with symptomatic outcomes and side effect burden in a trial of chamomile extract forgeneralized anxiety disorder. Journal of Psychiatric Research, 84, 90–97. https://doi.org/10.1016/j.jpsychires.2016.09.029 .
17. *Keefe, J. R., Guo, W., Li, Q. S., Amsterdam, J. D., & Mao, J. J. (2018). An exploratory study of salivary cortisol changes during chamomile extract therapy of moderate to severe generalized anxiety disorder. Journal Of Psychiatric Research, 96, 189-195.
18. Mao, J. J., Li, Q. S., Soeller, I., Rockwell, K., Xie, S. X., & Amsterdam, J. D. (2014). Long-Term Chamomile Therapy of Generalized Anxiety Disorder: A Study Protocol for a Randomized, Double-Blind, Placebo- Controlled Trial. Journal of Clinical Trials, 4(5). https://doi.org/10.4172/2167-0870.1000188.
19. *Mao JJ, Xie SX, Keefe JR, Soeller I, Li QS, Amsterdam JD. Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial. Phytomedicine. 2016; 23(14):1735–1742. [PubMed: 27912875].
20. Moher, D., Liberati, A., Tetzlaff, J., and Altman, D.G., (2009). PRISMA Group, 2009. Reprint—preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA statement. Physical Therapy, 89, 873-880. Rafii, F., Ameri, F., Haghani, H., & Ghobadi, A. (2020). The effect of aromatherapy massage with lavender and chamomile oil on anxiety and sleep quality of patients with burns. Burns, 46(1), 164-171.
21. Ross, S. M. (2013). Generalized Anxiety Disorder (GAD): Efficacy of Standardized: Matricaria recutita:(German Chamomile) Extract in the Treatment of Generalized Anxiety Disorder. Holistic Nursing Practice, 27(6), 366-368.
22. Tiller, J. W. G. (2013). Depression and anxiety. The Medical Journal of Australia, 199(6), S28–S31. https://doi.org/10.5694/MJA12.10628.
23. The Joanna Briggs Institute Critical Appraisal Tools Foruse in IBI Systematic Reviews. http://joannabriggs.org/research/critical-appraisal-tools.html(25.11.2021).
24. Tufanaru, C., Munn, Z., Aromataris, E., Campbell, J., and Hopp, L. (2017). Chapter 3: Systematic Reviews of Effectiveness. In: Aromataris E, Munn Z (Editors). Joanna Briggs Institute Reviewer’s Manual. The Joanna Briggs Institute.
25. WHO. (2021). Depression. https://www.who.int/news-room/fact-sheets/detail/depression. Accessed date(01.05.2022).
26. Yi, L. T., Li, J. M., Li, Y. C., Pan, Y., Xu, Q., & Kong, L. D. (2008). Antidepressant-like behavioral and neurochemical effects of the citrus-associated chemical apigenin. Life sciences, 82(13-14), 741-751.
27. Zamanifar, S., Bagheri-Saveh, M. I., Nezakati, A., Mohammadi, R., & Seidi, J. (2020). The effect of music therapy and aromatherapy with chamomile-lavender essential oil on the anxiety of clinical nurses: A randomized and double-blind clinical trial. Journal of medicine and life, 13(1), 87.
28. Zick, S. M., Wright, B. D., Sen, A., & Arnedt, J. T. (2011). Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary insomnia: a randomized placebo-controlled pilot study. BMC complementary and alternative medicine, 11(1), 1-8.